University of Dundee

Drug Discovery Unit

Short Code: 
DDU

School Prizes awarded at Review of the Year

A number of school prizes were presented at Review of the Year today.

Innovator of the Year

New for this year, Innovator of the Year, two categories were introduced for best innovation and for early-stage new business ideas. In partnership with the Centre of Entrepreneurship, the winners are guaranteed an automatic place in the appropriate category of the University of Dundee, Venture 2019 Final, plus a chance to participate in the on-campus three month summer Elevator accelerator programme.

Horn lab challenge trypanosome energy production dogma

Parasitic protozoa called trypanosomes synthesize sugars using an unexpected metabolic pathway called gluconeogenesis, according to a new study published in the open-access journal PLOS Pathogens. The research led by Professor David Horn's team, in particular lead author Dr Julie Kovarova, in collaboration with Professors Mike Ferguson (Dundee) and Mike Barrett (Glasgow) note that this metabolic flexibility may be essential for adaptation to environmental conditions and survival in mammalian host tissues.

Male contraceptive quest boosted by funding from Bill & Melinda Gates Foundation

The quest of researchers at the University of Dundee to develop a new male contraceptive has been boosted with a grant from the Bill & Melinda Gates Foundation. Researchers say the $900,000-plus award will enable significant progress to be made over the next two years in the discovery and development of the first safe and effective male contraceptive drug.

International collaboration provides new insights into the fight against African sleeping sickness

The African trypanosome causes African sleeping sickness, a hideous disease transmitted by the tsetse fly that, untreated, leads to character disintegration, comma and death. The trypanosome parasite evades the patient’s immune system by ‘antigenic variation’, which is the swapping one protective surface coat for another. 

Professor Victoria Cowling receives Royal Society Wolfson Research Merit Award

Professor Victoria Cowling was selected by UK Research and Innovation (UKRI) as one of their case studies for the launch last week of their new prestigious £900 million Future Leaders Fellowship Scheme. In 2007, she was a recipient of UK government funding through a Medical Research Council (MRC) Career Development Award. This initial investment in Vicky to allowed her to study a cancer-causing protein called Myc.

Pages